Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELAS PHARMACIE BEX : revenue, balance sheet and financial ratios

SELAS PHARMACIE BEX is a French company founded 31 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in CAMARET-SUR-AIGUES (84850), this company of category PME shows in 2019 a net income positive of 191 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS PHARMACIE BEX (SIREN 403480254)
Indicator 2019 2018 2017 2016
Revenue N/C N/C N/C N/C
Net income 191 197 € 41 790 € 50 897 € 56 402 €
EBITDA N/C N/C N/C N/C
Net margin N/C N/C N/C N/C

Revenue and income statement

In 2019, SELAS PHARMACIE BEX generates positive net income of 191 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2019: 56 k€ -> 191 k€.

Net income (2019) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

191 197 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 93%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2019) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

3.861%

Financial autonomy (2019) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

92.54%

Solvency indicators evolution
SELAS PHARMACIE BEX

Sector positioning

Debt ratio
3.86 2019
2017
2018
2019
Q1: 35.66
Med: 104.09
Q3: 243.68
Excellent

In 2019, the debt ratio of SELAS PHARMACIE BEX (3.86) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
92.54% 2019
2017
2018
2019
Q1: 22.98%
Med: 40.69%
Q3: 60.85%
Excellent

In 2019, the financial autonomy of SELAS PHARMACIE BEX (92.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 2417.08. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2019) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

2417.08

Liquidity indicators evolution
SELAS PHARMACIE BEX

Sector positioning

Liquidity ratio
2417.08 2019
2017
2018
2019
Q1: 119.98
Med: 167.07
Q3: 236.26
Excellent +27 pts over 3 years

In 2019, the liquidity ratio of SELAS PHARMACIE BEX (2417.08) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of SELAS PHARMACIE BEX in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 205 transactions of similar company sales in 2019, the value of SELAS PHARMACIE BEX is estimated at 2 376 240 € (range 1 415 427€ - 3 373 018€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2019
205 transactions
1415k€ 2376k€ 3373k€
2 376 240 € Range: 1 415 427€ - 3 373 018€
NAF 5 année 2019

Valuation method used

Net Income Multiple
191 197 € × 12.4x = 2 376 240 €
Range: 1 415 428€ - 3 373 018€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 205 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS PHARMACIE BEX with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS PHARMACIE BEX

What is the revenue of SELAS PHARMACIE BEX ?

The revenue of SELAS PHARMACIE BEX is not publicly disclosed (confidential accounts filed with INPI).

Is SELAS PHARMACIE BEX profitable?

Yes, SELAS PHARMACIE BEX generated a net profit of 191 k€ in 2019.

Where is the headquarters of SELAS PHARMACIE BEX ?

The headquarters of SELAS PHARMACIE BEX is located in CAMARET-SUR-AIGUES (84850), in the department Vaucluse.

Where to find the tax return of SELAS PHARMACIE BEX ?

The tax return of SELAS PHARMACIE BEX is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS PHARMACIE BEX operate?

SELAS PHARMACIE BEX operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.